Page last updated: 2024-08-24

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Hypesthesia

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Hypesthesia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandre, J; Batteux, F; Benoit, E; Borderie, D; Chéreau, C; Coriat, R; Coste, J; Goldwasser, F; Lemaréchal, H; Mir, O; Nicco, C; Quinquis, L; Tréluyer, JM; Weill, B1

Trials

1 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Hypesthesia

ArticleYear
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:1

    Topics: Action Potentials; Administration, Intravenous; Aged; Animals; Antineoplastic Agents; Antioxidants; Colorectal Neoplasms; Edetic Acid; Female; Humans; Hypesthesia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Middle Aged; Motor Activity; Muscle Contraction; Muscle, Skeletal; Nociception; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Peripheral Nervous System Diseases; Pyridoxal Phosphate; Sciatic Nerve; Survival Analysis

2014